Regeneron Pharmaceuticals | REGN - Market Capitalization


Regeneron Pharmaceuticals reported $88.38B in Market Capitalization this October of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 444.6B 59.91B Jun/2026
Agenus USD 128M 21M Mar/2026
Alnylam Pharmaceuticals USD 40.19B 3.96B Jun/2026
Amgen USD 195.44B 5.55B Jun/2026
Astellas Pharma JPY 3.94T 622.52B Jun/2026
AstraZeneca USD 289.99B 11.26B Jun/2026
Biogen USD 31.9B 5B Jun/2026
BioMarin Pharmaceutical USD 11.06B 196M Jun/2026
Bristol-Myers Squibb USD 117.66B 6.17B Jun/2026
Eli Lilly USD 1.13T 260.54B Jun/2026
Gilead Sciences USD 196.01B 39.15B Oct/2026
GlaxoSmithKline GBP 80.14B 3.66B Jun/2026
Incyte USD 22.65B 3.92B Jun/2026
Ionis Pharmaceuticals USD 13.1B 642M Jun/2026
J&J USD 607B 46.61B Oct/2026
Kyowa Hakko Kirin JPY 1.36T 4.73B Jun/2026
Merck USD 317.37B 20.27B Jun/2026
Neurocrine Biosciences USD 16.95B 3.7B Jun/2026
Novartis USD 240.59B 67.17B Jun/2026
Novartis USD 288.26B 25.18B Mar/2026
Pfizer USD 138.44B 15.37B Jun/2026
Regeneron Pharmaceuticals USD 65.37B 16.31B Jun/2026
Roche Holding CHF 270B 3.66B Jun/2026
Sanofi EUR 113.52B 3.82B Mar/2026
Sarepta Therapeutics USD 1.9B 388M Jun/2026
Teva Pharmaceutical Industries USD 114.54B 80.27B Jun/2026
Ultragenyx Pharmaceutical USD 3.29B 1.23B Jun/2026
United Therapeutics USD 23B 2.19B Jun/2026
Vertex Pharmaceuticals USD 126.07B 12.49B Jun/2026